Latest News and Press Releases
Want to stay updated on the latest news?
-
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
-
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
-
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
-
Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
-
Sol-Gel Technologies Announces Management Realignment
-
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
-
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
-
Sol-Gel and Beimei Pharma annouce an Asset Purcase Agreement to commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
-
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
-
Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments